Delay in treatment of early-stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program

Journal of Surgical Oncology

Volumn 103, Issue 2, 2011, Pages 133-139

  Chen, Wei Ting ^a   Fernandes, Mark Lee ^a,b   Lin, Chen Chun ^a   Lin, Shi Ming ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

hepatocellular carcinoma; radiofrequency ablation; surveillance; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE; THERAPY DELAY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHRONIC DISEASE; COMORBIDITY; CONFIDENCE INTERVALS; DELAYED DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79251471776     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21797     Document Type: Article

References (34)

1. El-Serag HB, Mason AC:, Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
2. Zhang BH, Yang BH, Tang ZY:, Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-422.
3. Sangiovanni A, Del Ninno E, Fasani P, et al.: Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014.
4. Wong GL, Wong VW, Tan GM, et al.: Surveillance program for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis. Liver Int 2008; 28: 79-87.
5. Izzo F, Cremona F, Ruffolo F, et al.: Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg 1998; 227: 513-518.
6. Olthoff KM:, Surgical options for hepatocellular carcinoma: Resection and transplantation. Liver Transpl Surg 1998; 4: S98-S104.
7. Llovet JM, Fuster J, Jordi Bruix for the Barcelona Clinic Liver Cancer (BCLC) Group: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999; 30: 1434-1440.
8. Livraghi T, Meloni F, Di Stasi M, et al.: Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice ? Hepatology 2008; 47: 82-89.
9. Lin SM, Lin CJ, Lin CC, et al.: Randomised controlled trial comparing percutaneous radio-frequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156.
10. Shiina S, Teratani T, Obi S, et al.: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
11. Lencioni RA, Allgaier HP, Cioni D, et al.: Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus ethanol injection. Radiology 2003; 228: 235-240.
12. Trevisani F, De NS, Rapaccini G, et al.: Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: Effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002; 97: 734-744.
13. Thompson Coon J, Rogers G, Hewson P, et al.: Surveillance of cirrhosis for hepatocellular carcinoma: A cost-utility analysis. Br J Cancer 2008; 98: 1166-1175.
14. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
15. Edmondson HA, Steiner PE:, Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503.
16. Lin SM, Lin CC, Chen WT, et al.: Radiofrequency ablation for hepatocellular carcinoma: A prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 2007; 18: 1118-1125.
17. Dodd GD III, Frank MS, Aribandi M, et al.: Radiofrequency thermal ablation: Computer analysis of the size of the thermal injury created by overlapping ablations. Am J Roentgenol 2001; 177: 777-782.
18. Mulier S, Ni Y, Jamart J, et al.: Local recurrence after hepatic radiofrequency coagulation: Multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158-171.
19. Goldberg SN, Grassi CJ, Cardella JF, et al.: Society of Interventional Radiology Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009; 20: S377-S390.
20. Schwartz M:, A biomathematical approach to clinical tumor growth. Cancer 1961; 14: 1272-1294.
21. Sacks D, McClenny TE, Cardella JF, et al.: Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14: S199-S202.
22. Yoshino M:, Growth kinetics of hepatocellular carcinoma. Jpn J Clin Oncol 1983; 13: 45-52.
23. Barbara L, Benzi G, Gaiani S, et al.: Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-137.
24. Sheu J, Sung J, Chen D, et al.: Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-266.
25. Ebara M, Ohto M, Shinagawa T, et al.: Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. Gastroenterology 1986; 90: 289-298.
26. Oken MM, Creech RH, Tormey DC, et al.: Toxicity and Response Criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
27. The Cancer of the Liver Italian Program (CLIP) Investigators: Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 40-45.
28. Mazzaferro V, Battiston C, Perrone S, et al.: Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: A prospective study. Ann Surg 2004; 240: 900-909.
29. Lu DS, Yu NC, Raman SS, et al.: Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130-1137.
30. Huo TI, Huang YH, Chiang JH, et al.: Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias ? Scand J Gastroenterol 2007; 42: 485-492.
31. Esnaola NF, Lauwers GY, Mirza NQ, et al.: Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002; 6: 224-232.
32. Sumie S, Kuromatsu R, Okuda K, et al.: Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382.
33. Sala M, Llovet JM, Vilana R, et al.: Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004; 40: 352-1360.
34. Huo TI, Huang YH, Wu JC, et al.: Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: A prospective study. Ann Oncol 2004; 15: 775-780.